Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

71
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
71
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.8K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

64
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
64
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

58
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
58
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

60
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
60
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

67
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
67

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Recognition and Spatial Confinement in CD-MOF Drive Tandem Photocatalytic CO<sub>2</sub> Reduction and Alcohol Oxidation.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Electrospinning Achieving Supramolecular Cyclodextrin-Polyaniline Layered Fabric for Expanding Conductive Performance of Flexible Electrode.

Macromolecular rapid communications·2026
Same author

Cucurbit[8]Uril Achieved Single-Molecule Chiral Transfer to Supramolecular Circularly Polarized Luminescence.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Multi-Level Confinement Single-Molecule Charge Transfer Activated PRET for Near-Infrared Targeted Cell Imaging.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Temperature-Responsive Supramolecular Chiral Switch Achieved by Macrocyclic Confinement.

JACS Au·2026
Same author

Cyclodextrin-Based Supramolecular Crosslinking Polymers With Multiple Ruthenium Centers for Highly Efficient Electrocatalytic Ammonia Synthesis.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025

Related Experiment Video

Updated: Mar 9, 2026

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules
11:13

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules

Published on: August 19, 2015

8.8K

Camptothecin-Polysaccharide Co-assembly and Its Controlled Release.

Yang Yang1,2, Ying-Ming Zhang1, Dizao Li1

  • 1Department of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin) , Tianjin 300071, P. R. China.

Bioconjugate Chemistry
|December 22, 2016
PubMed
Summary

This study developed a novel nanoparticle by modifying camptothecin (CPT) with β-cyclodextrin (CPT-CD) and hyaluronic acid (HA-ADA). The resulting CPT-loaded nanoparticles show effective cancer cell targeting with reduced side effects.

More Related Videos

Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries
10:58

Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries

Published on: September 6, 2012

10.8K
Activation and Conjugation of Soluble Polysaccharides using 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate CDAP
07:20

Activation and Conjugation of Soluble Polysaccharides using 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate CDAP

Published on: June 14, 2021

7.9K

Related Experiment Videos

Last Updated: Mar 9, 2026

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules
11:13

Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules

Published on: August 19, 2015

8.8K
Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries
10:58

Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries

Published on: September 6, 2012

10.8K
Activation and Conjugation of Soluble Polysaccharides using 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate CDAP
07:20

Activation and Conjugation of Soluble Polysaccharides using 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate CDAP

Published on: June 14, 2021

7.9K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Cancer Therapeutics

Background:

  • Camptothecin (CPT) is a potent anticancer drug with poor aqueous solubility and significant toxicity.
  • Developing effective drug delivery systems is crucial for improving CPT's therapeutic index.

Purpose of the Study:

  • To synthesize a novel supramolecular nanoparticle for improved camptothecin (CPT) delivery.
  • To enhance CPT solubility and achieve targeted cancer cell delivery.
  • To reduce CPT-induced side effects.

Main Methods:

  • Synthesis of β-cyclodextrin modified camptothecin (CPT-CD) via esterification and click chemistry.
  • Construction of supramolecular nanoparticles using CPT-CD and adamantane-modified hyaluronic acid (HA-ADA).
  • Evaluation of nanoparticle cytotoxicity and anticancer activity in vitro.

Main Results:

  • Successfully synthesized CPT-CD, significantly improving CPT aqueous solubility.
  • Constructed nanoparticles with a hydrophilic HA shell for targeted delivery and a hydrophobic CPT core.
  • Demonstrated comparable in vitro anticancer efficacy to commercial CPT but with substantially lower side effects.

Conclusions:

  • The developed HA-shelled nanoparticle system effectively delivers CPT to cancer cells.
  • This strategy offers a promising approach for enhancing CPT's clinical efficacy and minimizing toxicity.
  • The findings support the potential of this nanoparticle system for improved cancer treatment.